Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  
hematology_autoimmune

Hematology CRO Services

Extensive Hematology Expertise. Going the Distance – Helping You Create a Healthier World. 

hematology_autoimmune

Full-Service Hematology CRO Services

Our deep expertise in hematology encompasses liquid tumors, autoimmune hematological diseases, hematological rare diseases, various blood disorders and includes Phase I to Phase III global trials.

Choose Pharm-Olam

Hematology Expertise By The Numbers

Pharm-Olam
0
Studies
Pharm-Olam
0
Number of patients
Pharm-Olam
0
Sites

aTTP Case Study Image@2x-100

 

Case Study: Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Acquired Thrombotic Thrombocytopenic Purpura (aTTP) is a rare blood disorder that, when left untreated leads to a 95% morbidity rate.  This case study provides an overview of a recent Phase III study, we partnered with a progressive sponsor company to assist in finding a better solution for patients suffering with aTTP.

Read the case study

aTTP Case Study Image@2x-100

 

Hematology Expertise

Blood Disorders

Blood disorders and other hematological conditions are becoming increasingly frequent – and with them, the research. From relatively common disorders such as anemia to blood cancers and platelet disorders, hematology research is experiencing new breakthroughs. Choose a Hematology CRO that has the knowledge and experience to execute complex studies with today’s best supportive technologies.

 

Blood Cancer CRO Services

We have run multiple studies in the three main blood cancers; leukemia, lymphoma and myeloma. Pharm-Olam is focused on early phase oncology and maintains therapeutically aligned staff for ready to initiate your next oncology clinical trials. To learn more about our extensive Oncology CRO expertise, click below.

Oncology CRO Services >>

Autoimmune Hematological Disorders

Pharm-Olam has vast hematology expertise, having supported idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia among numerous others.  Our team goes the distance for patients in need. To learn more about our Autoimmune CRO Services, click below.

Autoimmune CRO Services >>

Hematological Rare Diseases

At Pharm-Olam, we understand hematological issues including rare conditions like Myelofibrosis. We have supported numerous hematological rare disease clinical trials which lead to marketed products for patients in need. To learn more about our Rare Disease CRO Services, click below.

Rare Disease CRO Services >>

Pharm-Olam

Hematology CRO Expertise

It’s important to choose a team that has the right kind of therapeutic experience for your clinical trial. Our teams have executed studies for hematology treatments across a wide variety of indications:

Anemia
Anticoagulant Reversal
Autoimmune Hemolytic Anemia
Blood Loss
Essential Thrombocythaemia
Graft Versus Host Disease
Hereditary Angioedema
Hyperbilirubinemia (Genetic)
Leukemia
Lymphoma
Myelofibrosis
Myeloma
Neutropenia
Paroxysmal Nocturnal
Sickle Cell Anemia
Thrombotic Thrombocytopenic Purpura

Need a partner for your next allergy clinical trial?

Talk with our team today.  

Please choose one.

Contact Us